We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Rejects Teva’s Arguments, Invalidates Its Crestor Patent
Court Rejects Teva’s Arguments, Invalidates Its Crestor Patent
December 6, 2011
A federal appeals court has affirmed a lower court decision invalidating Teva’s stabilizing formulation patent for blockbuster AstraZeneca cholesterol drug Crestor.